Keyphrases
Acute Coronary Syndrome
100%
Atrial Fibrillation
33%
Temporal Trends
32%
Israeli
30%
Percutaneous Coronary Intervention
28%
Clinical Outcomes
28%
1-year Mortality
26%
Myocardial Infarction
21%
Clinical High Risk
19%
High Risk
18%
Heart Failure
17%
Major Adverse Cardiovascular Events
15%
Statins
14%
Cardiac Resynchronization Therapy
14%
Coronary Artery Disease
14%
ST-elevation Myocardial Infarction (STEMI)
13%
Cardiovascular Disease
12%
Edoxaban
12%
Type 1 Diabetes Mellitus (T1DM)
12%
Recurrent Cardiovascular Events
12%
Human Endothelial Progenitor Cells
12%
Cardiovascular Events
11%
Thrombolysis in Myocardial Infarction
11%
Patients with Coronary Artery Disease
11%
Cardioverter-defibrillator Implantation
11%
Estimated Glomerular Filtration Rate
11%
Chest Pain
11%
Cardiovascular Risk
10%
Risk Factors
10%
Warfarin
10%
Hazard Ratio
10%
Non-ST-segment Elevation Acute Coronary Syndrome (NSTE-ACS)
9%
Abdominal Pain
9%
Diarrhea
9%
Young Women
9%
Prior Myocardial Infarction
9%
Atherosclerotic Disease
9%
Guideline-directed Medical Therapy
9%
Stable Coronary Artery Disease
9%
Implantable Defibrillator
8%
Non-valvular Atrial Fibrillation
8%
Angina Pectoris
8%
Peripheral Arterial Disease
8%
Cardiovascular Mortality
8%
Secondary Prevention
8%
High-risk Population
8%
ENGAGE AF-TIMI 48
8%
Cardiac Amyloidosis
8%
Proprotein Convertase Subtilisin/kexin Type 9 Inhibitors
8%
ST-segment Elevation
8%
Medicine and Dentistry
Acute Coronary Syndrome
79%
Cardiovascular System
31%
Coronary Artery Disease
26%
Myocardial Infarction
25%
Cardiovascular Disease
25%
Percutaneous Coronary Intervention
19%
ST Elevation
15%
Endothelial Progenitor Cell
15%
Cardiac Resynchronization Therapy
15%
Heart Failure
14%
Cardiovascular Risk
13%
Disease
12%
Defibrillator
12%
Implantable Automatic Defibrillator
12%
Thorax Pain
11%
Heart Amyloidosis
11%
Antiplatelet
11%
Proprotein Convertase 9
10%
Cardiology
10%
Diabetes Mellitus
9%
Diarrhea
9%
Abdominal Pain
9%
Symptom
9%
COVID-19
9%
ST Segment Elevation Myocardial Infarction
8%
Kidney Function
8%
All Cause Mortality
8%
Stable Angina Pectoris
8%
Atrial Fibrillation
7%
Coronary Artery
7%
Blood Clot Lysis
7%
Prevalence
7%
Pericarditis
7%
Spiral Computed Tomography
7%
Pericardium Cyst
7%
Sudden Cardiac Death
7%
Percutaneous Aortic Valve Replacement
7%
Hazard Ratio
7%
High Risk Population
7%
Secondary Prevention
7%
Thoracic Aorta
6%
Arteriosclerosis Obliterans
6%
Cohort Analysis
6%
Major Adverse Cardiac Event
5%
Transthyretin
5%
Ticagrelor
5%
Vasculotropin Receptor 2
5%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Coronary Syndrome
59%
Coronary Artery Disease
33%
Heart Infarction
31%
Atrial Fibrillation
26%
Disease
26%
Heart Failure
25%
Cardiovascular Disease
21%
Statin (Protein)
17%
Diabetes Mellitus
13%
Edoxaban
12%
Proprotein Convertase 9
11%
Antiplatelet
11%
All Cause Mortality
11%
Warfarin
10%
Cardiovascular Risk
9%
Acetylsalicylic Acid
9%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
9%
Thorax Pain
8%
Clopidogrel
8%
Stable Angina Pectoris
8%
Prevalence
8%
Acute Kidney Failure
7%
Pericarditis
7%
Vaccination Policy
7%
Heart Ventricle Tachycardia
7%
ST Segment Elevation Myocardial Infarction
6%
Peripheral Occlusive Artery Disease
6%
Adverse Event
6%
Vasculotropin Receptor 2
6%
Creatinine
6%
Adverse Outcome
6%
Coronavirinae
6%
Anticoagulant Agent
5%
Low Density Lipoprotein Cholesterol
5%
Sudden Cardiac Death
5%
Myocarditis
5%
Coronary Artery Atherosclerosis
5%
Bleeding
5%
Symptom
5%
Inflammation
5%
Chronic Kidney Failure
5%
